Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient

被引：0

作者：

Popa, Gheorghe ^{[1
]}

Blag, Cristina ^{[1
]}

Olteanu, Horatiu ^{[2
]}

机构：

[1] Iuliu Hatieganu Univ Med & Pharm, Pediat Clin 2, Dept Pediat Oncol, Cluj Napoca, Romania

[2] Med Coll Wisconsin, Dept Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

来源：

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | 2017年 / 20卷 / 01期

关键词：

chronic myelogenous leukemia; lymphoblastic leukemia/lymphoma; cytogenetics; flow cytometry; BCR-ABLI; CHRONIC MYELOID-LEUKEMIA; CHRONIC GRANULOCYTIC-LEUKEMIA; CHILDREN;

D O I：

10.1177/1093526616671047

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in children and presents even less often as a secondary malignancy in the pediatric population. Below, we report a patient with Philadelphia-negative B-lymphoblastic leukemia/lymphoma, who developed CML several years after achieving complete remission, and summarize the existing literature on the clinical and pathologic features of CML as a secondary pediatric malignancy.

引用

页码：58 / 62

页数：5

共 50 条

[31] Chronic Myelogenous Leukemia Presenting in Blast Phase with Nodal, Bilineal Myeloid Sarcoma and T-Lymphoblastic Lymphoma in a Child [J].

Chen, Xueyan ;

Rutledge, Joe C. ;

Wu, David ;

Fang, Min ;

Opheim, Kent E. ;

Xu, Min .

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2013, 16 (02) :91-96

[32] A modified DAW-22 compound F-B1 inhibits Bcr/Abl and induces apoptosis in chronic myelogenous leukemia cells [J].

Wang, Fengling ;

Wang, Jinhui ;

Chong, Zhaozhong ;

Mu, Yanling .

ANTI-CANCER DRUGS, 2019, 30 (02) :159-166

[33] Myeloid blast phase of chronic myelogenous leukemia, BCR-ABL1+, associated with a secondary translocation involving MLL: case report and review of the literature [J].

Elena Vrotsos ;

Eileen Gillan ;

Laila Mnayer ;

Joseph A. DiGiuseppe .

Journal of Hematopathology, 2016, 9 :29-33

[34] Myeloid blast phase of chronic myelogenous leukemia, BCR-ABL1+, associated with a secondary translocation involving MLL: case report and review of the literature [J].

Vrotsos, Elena ;

Gillan, Eileen ;

Mnayer, Laila ;

DiGiuseppe, Joseph A. .

JOURNAL OF HEMATOPATHOLOGY, 2016, 9 (01) :29-33

[35] γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia [J].

Luong-Gardiol, Noemie ;

Siddiqui, Imran ;

Pizzitola, Irene ;

Jeevan-Raj, Beena ;

Charmoy, Melanie ;

Huang, Yun ;

Irmisch, Anja ;

Curtet, Sara ;

Angelov, Georgi S. ;

Danilo, Maxime ;

Juilland, Melanie ;

Bornhauser, Beat ;

Thome, Margot ;

Hantschel, Oliver ;

Chalandon, Yves ;

Cazzaniga, Gianni ;

Bourquin, Jean-Pierre ;

Huelsken, Joerg ;

Held, Werner .

CANCER CELL, 2019, 35 (04) :649-+

[36] BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: A case report [J].

Cornea M.I.P. ;

Levrat E. ;

Pugin P. ;

Betticher D.C. .

Journal of Medical Case Reports, 9 (1)

[37] Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia [J].

Vey, N ;

Balatzentko, G ;

LaFage, M ;

Sainty, D ;

Bouabdallah, R ;

Chabannon, C ;

Blaise, D ;

Gastaut, JA ;

Gabert, J .

LEUKEMIA & LYMPHOMA, 2001, 42 (05) :945-952

[38] Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors [J].

Lin, Jay ;

Makenbaeva, Dinara ;

Lingohr-Smith, Melissa ;

Bilmes, Robyn .

JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) :687-691

[39] BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy [J].

Pereira, Welbert O. ;

De Carvalho, Daniel D. ;

Zenteno, Maria Emilia ;

Ribeiro, Beatriz F. ;

Jacysyn, Jacqueline F. ;

Sardinha, Luiz R. ;

Zanichelli, Maria A. ;

Hamerschlak, Nelson ;

Jones, Gareth E. ;

Pagnano, Katia B. ;

Castro, Fabiola A. ;

Calle, Yolanda ;

Amarante-Mendes, Gustavo P. .

CELL DEATH & DISEASE, 2017, 8 :e3114-e3114

[40] Loss of Egr1, a human del5q gene, accelerates BCR-ABL driven chronic myelogenous leukemia [J].

Maifrede, Silvia ;

Magimaidas, Andrew ;

Sha, Xiaojin ;

Mukherjee, Kaushiki ;

Liebermann, Dan A. ;

Hoffman, Barbara .

ONCOTARGET, 2017, 8 (41) :69281-69294

← 1 2 3 4 5 →